Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Methysergide | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Methysergide | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Methysergide | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | | Methysergide | hsa00510 | N-Glycan biosynthesis | 3.15E-02 | 2 | P15907, Q9NR34 | ST6GAL1, MAN1C1 | More | | Methysergide | hsa00600 | Sphingolipid metabolism | 3.76E-02 | 1 | P15289 | ARSA | More | | Methysergide | hsa00630 | Glyoxylate and dicarboxylate metabolism | 8.89E-04 | 3 | P40926, P05166, P15104 | MDH2, PCCB, GLUL | More | | Methysergide | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Methysergide | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Methysergide | hsa00900 | Terpenoid backbone biosynthesis | 4.22E-02 | 2 | P49354, Q9UHG3 | FNTA, PCYOX1 | More | | Methysergide | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | | Methysergide | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Methysergide | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Methysergide | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | | Methysergide | hsa03013 | RNA transport | 5.66E-03 | 8 | P62826, Q15287, Q9UBU9, P35658, P63279, P68104, P55884, Q9H777 | RAN, RNPS1, NXF1, NUP214, UBE2I, EEF1A1, EIF3B, ELAC1 | More | | Methysergide | hsa03040 | Spliceosome | 1.46E-02 | 4 | P17844, P51991, P61978, P11142 | DDX5, HNRPA3, HNRPK, HSPA8 | More | | Methysergide | hsa03410 | Base excision repair | 7.59E-03 | 1 | P27695 | APEX1 | More | | Methysergide | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | | Methysergide | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Methysergide | hsa04015 | Rap1 signaling pathway | 9.14E-03 | 2 | P06213, O00522 | INSR, KRIT1 | More | | Methysergide | hsa04020 | Calcium signaling pathway | 1.24E-02 | 6 | Q96DU7, Q08828, Q13557, P21860, P0DP24, P05141 | ITPKC, ADCY1, CAMK2D, ERBB3, CALM2, SLC25A5 | More | | Methysergide | hsa04022 | cGMP-PKG signaling pathway | 2.84E-02 | 6 | Q02153, Q99941, P18848, Q08828, P05141, P0DP24 | GUCY1B3, CREBL1, ATF4, ADCY1, SLC25A5, CALM2 | More | | Methysergide | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Methysergide | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | | Methysergide | hsa04064 | NF-kappa B signaling pathway | 1.98E-04 | 15 | P10415, O00463, P14778, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q13315, P24522, P09341, P19875, Q06643 | BCL2, TRAF5, IL1R1, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, ATM, GADD45A, CXCL1, CXCL2, LTB | More | | Methysergide | hsa04070 | Phosphatidylinositol signaling system | 1.53E-02 | 2 | Q86XP1, Q96DU7 | DGKH, ITPKC | More | | Methysergide | hsa04071 | Sphingolipid signaling pathway | 6.08E-04 | 5 | P21453, Q9H228, P01375, Q13362, Q9UQC2 | S1PR1, EDG8, TNF, PPP2R5C, GAB2 | More | | Methysergide | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Methysergide | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | | Methysergide | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Methysergide | hsa04140 | Autophagy - animal | 4.55E-02 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Methysergide | hsa04141 | Protein processing in endoplasmic reticulum | 5.27E-04 | 8 | P18848, Q15437, Q15436, Q99941, P11142, Q9H3Z4, P07900, Q9NR31 | ATF4, SEC23B, SEC23A, CREBL1, HSPA8, DNAJC5, HSP90AA1, SAR1A | More | | Methysergide | hsa04145 | Phagosome | 3.69E-02 | 7 | O75015, Q15080, P05164, P78380, O60603, P35443, P13765 | FCGR3B, NCF4, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Methysergide | hsa04151 | PI3K-Akt signaling pathway | 4.86E-04 | 11 | P62753, P21860, P27348, P07900, P62873, P61952, Q16363, P22105, Q99941, P18848, O00141 | RPS6, ERBB3, YWHAQ, HSP90AA1, GNB1, GNG11, LAMA4, TNXB, CREBL1, ATF4, SGK | More | | Methysergide | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Methysergide | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Methysergide | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Methysergide | hsa04217 | Necroptosis | 2.92E-03 | 10 | P01375, P48023, Q14765, P07900, P15104, P05141, P01584, P0C0S5, Q99878, Q13557 | TNF, FASLG, STAT4, HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC14, CAMK2D | More | | Methysergide | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.33E-03 | 7 | P07550, P51828, P22694, Q99941, P18848, Q13362, Q13557 | ADRB2, ADCY7, PRKACB, CREBL1, ATF4, PPP2R5C, CAMK2D | More | | Methysergide | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Methysergide | hsa04371 | Apelin signaling pathway | 3.80E-02 | 5 | P62873, P61952, Q08828, P62753, P0DP24 | GNB1, GNG11, ADCY1, RPS6, CALM2 | More | | Methysergide | hsa04612 | Antigen processing and presentation | 3.33E-04 | 8 | P13765, P48382, Q14953, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Methysergide | hsa04640 | Hematopoietic cell lineage | 2.27E-03 | 12 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD7, HLA-DOB, TNF | More | | Methysergide | hsa04650 | Natural killer cell mediated cytotoxicity | 4.87E-07 | 13 | P19174, P01375, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, Q14953, P26715 | PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | | Methysergide | hsa04657 | IL-17 signaling pathway | 2.10E-03 | 5 | P49841, P19875, P14780, P80188, P01375 | GSK3B, CXCL2, MMP9, LCN2, TNF | More | | Methysergide | hsa04658 | Th1 and Th2 cell differentiation | 4.98E-06 | 12 | Q04759, P07766, P20963, P09693, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Methysergide | hsa04659 | Th17 cell differentiation | 1.24E-04 | 12 | Q04759, P19174, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, PLCG1, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, CD3E, CD3G, CD247 | More | | Methysergide | hsa04660 | T cell receptor signaling pathway | 5.90E-05 | 13 | P01375, Q9UDY8, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239 | TNF, MALT1, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK | More | | Methysergide | hsa04668 | TNF signaling pathway | 1.48E-03 | 8 | P01375, Q99941, P18848, P19875, P01584, P14780, P20333, O95429 | TNF, CREBL1, ATF4, CXCL2, IL1B, MMP9, TNFRSF1B, BAG4 | More | | Methysergide | hsa04713 | Circadian entrainment | 4.35E-04 | 6 | P0DP24, Q13557, Q02153, P62873, P61952, Q08828 | CALM2, CAMK2D, GUCY1B3, GNB1, GNG11, ADCY1 | More | | Methysergide | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Methysergide | hsa04720 | Long-term potentiation | 2.60E-02 | 4 | Q13557, P0DP24, P18848, Q08828 | CAMK2D, CALM2, ATF4, ADCY1 | More | | Methysergide | hsa04722 | Neurotrophin signaling pathway | 1.98E-03 | 5 | Q05655, P49841, O43524, P48023, P52566 | PRKCD, GSK3B, FOXO3, FASLG, ARHGDIB | More | | Methysergide | hsa04723 | Retrograde endocannabinoid signaling | 3.71E-02 | 4 | P62873, P61952, Q08828, O15239 | GNB1, GNG11, ADCY1, NDUFA1 | More | | Methysergide | hsa04724 | Glutamatergic synapse | 2.60E-02 | 4 | Q08828, P62873, P61952, P15104 | ADCY1, GNB1, GNG11, GLUL | More | | Methysergide | hsa04725 | Cholinergic synapse | 6.66E-04 | 6 | Q08828, P51828, P62873, P61952, P18848, Q13557 | ADCY1, ADCY7, GNB1, GNG11, ATF4, CAMK2D | More | | Methysergide | hsa04727 | GABAergic synapse | 1.52E-02 | 5 | Q08828, P62873, P61952, P15104, Q15111 | ADCY1, GNB1, GNG11, GLUL, PLCL1 | More | | Methysergide | hsa04728 | Dopaminergic synapse | 2.50E-04 | 7 | P62873, P61952, Q99941, P18848, Q13557, P0DP24, O15516 | GNB1, GNG11, CREBL1, ATF4, CAMK2D, CALM2, CLOCK | More | | Methysergide | hsa04740 | Olfactory transduction | 1.17E-03 | 4 | P62873, Q9H255, Q13557, P0DP24 | GNB1, OR51E2, CAMK2D, CALM2 | More | | Methysergide | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Methysergide | hsa04744 | Phototransduction | 4.22E-02 | 2 | P62873, P0DP24 | GNB1, CALM2 | More | | Methysergide | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.19E-04 | 9 | P14778, P01584, Q08828, Q13557, P19174, P42338, P24723, Q04759, P0DP24 | IL1R1, IL1B, ADCY1, CAMK2D, PLCG1, PIK3CB, PRKCH, PRKCQ, CALM2 | More | | Methysergide | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Methysergide | hsa04911 | Insulin secretion | 2.15E-05 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | | Methysergide | hsa04912 | GnRH signaling pathway | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | | Methysergide | hsa04913 | Ovarian steroidogenesis | 2.45E-03 | 3 | P42330, P22694, P06213 | AKR1C3, PRKACB, INSR | More | | Methysergide | hsa04915 | Estrogen signaling pathway | 4.25E-04 | 7 | Q99941, P18848, Q08828, P51828, P07900, P11142, P0DP24 | CREBL1, ATF4, ADCY1, ADCY7, HSP90AA1, HSPA8, CALM2 | More | | Methysergide | hsa04918 | Thyroid hormone synthesis | 3.37E-04 | 5 | Q08828, P51828, Q99941, P18848, P02768 | ADCY1, ADCY7, CREBL1, ATF4, ALB | More | | Methysergide | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Methysergide | hsa04923 | Regulation of lipolysis in adipocytes | 4.24E-03 | 4 | P07550, P06213, P42338, Q9Y4H2 | ADRB2, INSR, PIK3CB, IRS2 | More | | Methysergide | hsa04924 | Renin secretion | 4.04E-02 | 2 | P22694, P07550 | PRKACB, ADRB2 | More | | Methysergide | hsa04925 | Aldosterone synthesis and secretion | 4.69E-05 | 6 | Q99941, P18848, Q08828, P51828, P0DP24, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, CALM2, CAMK2D | More | | Methysergide | hsa04926 | Relaxin signaling pathway | 1.50E-04 | 9 | P62873, P61952, Q99941, P18848, P22694, P14780, Q08828, P51828, P30679 | GNB1, GNG11, CREBL1, ATF4, PRKACB, MMP9, ADCY1, ADCY7, GNA15 | More | | Methysergide | hsa04927 | Cortisol synthesis and secretion | 3.49E-05 | 5 | Q99941, P18848, Q08828, P51828, P22694 | CREBL1, ATF4, ADCY1, ADCY7, PRKACB | More | | Methysergide | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.17E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Methysergide | hsa04930 | Type II diabetes mellitus | 1.48E-03 | 2 | P06213, Q05655 | INSR, PRKCD | More | | Methysergide | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Methysergide | hsa04932 | Non-alcoholic fatty liver disease | 3.08E-03 | 8 | P01375, P49841, P18848, P48023, P01584, P13073, P12074, O15239 | TNF, GSK3B, ATF4, FASLG, IL1B, COX4I1, COX6A1, NDUFA1 | More | | Methysergide | hsa04934 | Cushing syndrome | 1.55E-04 | 5 | Q99941, P18848, Q08828, P51828, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, CAMK2D | More | | Methysergide | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Methysergide | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Methysergide | hsa04960 | Aldosterone-regulated sodium reabsorption | 3.14E-02 | 1 | P06213 | INSR | More | | Methysergide | hsa04970 | Salivary secretion | 2.25E-03 | 6 | P07550, Q08828, P22694, P0DP24, Q02153, P49913 | ADRB2, ADCY1, PRKACB, CALM2, GUCY1B3, CAMP | More | | Methysergide | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Methysergide | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Methysergide | hsa05012 | Parkinson disease | 4.13E-02 | 8 | O15239, P13073, P12074, P05496, P05141, P18848, P0DP24, Q13557 | NDUFA1, COX4I1, COX6A1, ATP5G1, SLC25A5, ATF4, CALM2, CAMK2D | More | | Methysergide | hsa05020 | Prion disease | 1.86E-02 | 10 | P01584, P46531, P11142, O15239, P05496, P13073, P12074, P18848, P05141, Q99941 | IL1B, NOTCH1, HSPA8, NDUFA1, ATP5G1, COX4I1, COX6A1, ATF4, SLC25A5, CREBL1 | More | | Methysergide | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Methysergide | hsa05031 | Amphetamine addiction | 3.49E-05 | 6 | P0DP24, Q13557, P22694, Q99941, P18848, Q13547 | CALM2, CAMK2D, PRKACB, CREBL1, ATF4, HDAC1 | More | | Methysergide | hsa05034 | Alcoholism | 6.15E-03 | 6 | Q99941, P18848, P0DP24, P62873, P61952, P0C0S5 | CREBL1, ATF4, CALM2, GNB1, GNG11, H2AFZ | More | | Methysergide | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Methysergide | hsa05131 | Shigellosis | 2.57E-02 | 2 | Q05655, P07737 | PRKCD, PFN1 | More | | Methysergide | hsa05132 | Salmonella infection | 4.88E-02 | 2 | P84095, P07737 | RHOG, PFN1 | More | | Methysergide | hsa05134 | Legionellosis | 8.12E-04 | 7 | P01584, Q9NR31, P11215, P68104, P11142, P09341, P19875 | IL1B, SAR1A, ITGAM, EEF1A1, HSPA8, CXCL1, CXCL2 | More | | Methysergide | hsa05140 | Leishmaniasis | 3.53E-02 | 6 | P13612, O75015, P13765, O60603, P01375, Q15080 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, NCF4 | More | | Methysergide | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Methysergide | hsa05144 | Malaria | 6.75E-04 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Methysergide | hsa05146 | Amoebiasis | 2.46E-06 | 13 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P30679, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, GNA15, PRKACB, ACTN1, CTSG | More | | Methysergide | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Methysergide | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | | Methysergide | hsa05163 | Human cytomegalovirus infection | 2.89E-02 | 8 | P62873, P61952, P0DP24, Q08828, P01584, Q99941, P18848, P61769 | GNB1, GNG11, CALM2, ADCY1, IL1B, CREBL1, ATF4, B2M | More | | Methysergide | hsa05202 | Transcriptional misregulation in cancer | 2.35E-02 | 12 | Q13315, P14780, P27930, Q15744, Q16548, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | ATM, MMP9, IL1R2, CEBPE, BCL2A1, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Methysergide | hsa05203 | Viral carcinogenesis | 1.46E-02 | 4 | Q99941, P18848, P27348, P61978 | CREBL1, ATF4, YWHAQ, HNRPK | More | | Methysergide | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | | Methysergide | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | | Methysergide | hsa05310 | Asthma | 1.92E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Methysergide | hsa05321 | Inflammatory bowel disease | 1.17E-05 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Methysergide | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Methysergide | hsa05332 | Graft-versus-host disease | 7.00E-05 | 5 | P13765, P48023, P01375, P26715, Q13241 | HLA-DOB, FASLG, TNF, KLRC1, KLRD1 | More | | |